Cardiologie clinique et expérimentale
Libre accès

Abstrait

Early Intravenous Beta-blockers for Acute Myocardial Infarction

Shu Hong Guo, Yi He and Qiang Fu

Early intravenous beta-blockers reduce the risk of recurrent ischaemia and ventricular arrhythmia in the treatment of acute myocardial infarction. These beneficial efficacy, however, are balanced by a high rate of cardiogenic shock. It has great significance for reliable identification of subgroups of patients among whom treatment is really advantageous. The present article is a review on the efficacy and safety of the early intravenous beta-blockers, and provides an evaluation procedure to guide clinicians applying intravenous beta-blockers to clinical practice.